|
NOLC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.098430E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.596200E-03 |
| Normal-vs-Stage2 |
3.840800E-01 |
| Normal-vs-Stage3 |
4.244000E-01 |
| Normal-vs-Stage4 |
9.830100E-02 |
| Stage1-vs-Stage2 |
4.925200E-01 |
| Stage1-vs-Stage3 |
3.218400E-02 |
| Stage1-vs-Stage4 |
1.983730E-02 |
| Stage2-vs-Stage3 |
2.185800E-01 |
| Stage2-vs-Stage4 |
3.355800E-02 |
| Stage3-vs-Stage4 |
2.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.237610E-01 |
| Normal-vs-AfricanAmerican |
8.182000E-02 |
| Normal-vs-Asian |
7.983000E-01 |
| Caucasian-vs-AfricanAmerican |
5.895200E-01 |
| Caucasian-vs-Asian |
8.751800E-01 |
| AfricanAmerican-vs-Asian |
7.126200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.199900E-03 |
| Normal-vs-Female |
1.774980E-01 |
| Male-vs-Female |
3.583400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.613990E-01 |
| Normal-vs-Extreme_Weight |
2.999400E-03 |
| Normal-vs-Obese |
8.809800E-01 |
| Normal-vs-Extreme_Obese |
2.618000E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.024800E-01 |
| Normal_Weight-vs-Obese |
2.835600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.320000E-01 |
| Extreme_Weight-vs-Obese |
2.674300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.255800E-01 |
| Obese-vs-Extreme_Obese |
1.603870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.182400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.171400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.374300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.06240000000446E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.347700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.714240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.620430E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.402800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.389900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.464500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.239400E-03 |
| Normal-VS-Type2 PRCC |
2.196100E-02 |
| Normal-VS-KIRP CIMP |
7.765800E-04 |
| Normal-VS-Unclassified PRCC |
6.029800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.747600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.428800E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.037840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.977100E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.733960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.028400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.277460E-03 |
| Normal-vs-N1 |
1.631810E-02 |
| Normal-vs-N2 |
4.930600E-01 |
| N0-vs-N1 |
4.564800E-04 |
| N0-vs-N2 |
2.696000E-01 |
| N1-vs-N2 |
8.141200E-01 |
|
|
